Profile data is unavailable for this security.
About the company
Immunotech Biopharm Ltd is a China-based investment holding company mainly engaged in the research and development, manufacturing and commercialization of immune cell products for treatments of cancers. Its main products are EAL, CAR-T cell series and TCR-T cell series products. EAL is a multi-target cellular immunotherapy product. It also provides cell cryopreservation services. The Company mainly conducts its businesses in the domestic market.
- Revenue in HKD (TTM)0.00
- Net income in HKD-362.26m
- Incorporated2018
- Employees210.00
- LocationImmunotech Biopharm Ltd8th Floor, Building 1Guosheng Science and Technology ParkNo.1 Kangding Street, Economic and TechnBeijing ChinaCHN
- Websitehttp://www.eaal.net/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CStone Pharmaceuticals | 501.86m | -397.34m | 1.13bn | 230.00 | -- | 2.29 | -- | 2.25 | -0.315 | -0.315 | 0.3973 | 0.3849 | 0.2811 | 2.44 | 3.72 | 2,182,016.00 | -22.25 | -54.76 | -48.85 | -81.68 | 65.60 | -- | -79.17 | -301.62 | 1.44 | -- | 0.4431 | -- | -3.64 | -- | 59.32 | -- | 52.42 | -- |
| Jacobson Pharma Corporation Ltd | 1.68bn | 212.16m | 1.14bn | 1.59k | 5.12 | 0.4779 | 2.88 | 0.6774 | 0.1112 | 0.1409 | 0.8822 | 1.19 | 0.3722 | 2.87 | 7.50 | 940,829.50 | 5.16 | 4.91 | 6.61 | 6.60 | 42.05 | 41.81 | 13.85 | 14.32 | 1.01 | 5.62 | 0.3646 | 35.97 | 11.91 | 2.89 | 41.30 | 4.42 | -6.22 | 6.39 |
| VIVA Biotech Holdings | 2.33bn | -125.63m | 1.15bn | 2.08k | -- | 0.2845 | 9.46 | 0.4912 | -0.0639 | -0.0639 | 1.20 | 1.86 | 0.2805 | 4.84 | 5.13 | 1,122,905.00 | -1.30 | -1.39 | -1.79 | -1.68 | 34.26 | 34.81 | -4.63 | -5.44 | 1.15 | 0.035 | 0.3412 | -- | -9.42 | 59.31 | 78.03 | -- | -- | -- |
| Essex Bio-Technology Ltd | 1.71bn | 275.26m | 1.31bn | 1.48k | 4.91 | 0.6786 | 3.90 | 0.7649 | 0.4689 | 0.4689 | 2.87 | 3.39 | 0.6161 | 2.28 | 3.35 | 1,152,300.00 | 9.94 | 11.20 | 13.21 | 14.73 | 90.20 | 86.01 | 16.13 | 19.77 | 1.46 | -- | 0.1326 | 16.16 | 29.51 | 7.72 | 22.11 | 3.56 | 7.29 | 7.39 |
| Ascletis Pharma Inc | 61.24m | -156.58m | 1.32bn | 219.00 | -- | 0.5503 | -- | 21.50 | -0.1471 | -0.1471 | 0.057 | 2.36 | 0.022 | 2.30 | 3.86 | 279,613.00 | -5.62 | -6.43 | -5.91 | -6.64 | 45.92 | 35.67 | -255.70 | -243.38 | 16.54 | -6.09 | 0.0036 | -- | 4.63 | -19.39 | 54.04 | -- | -- | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 68.73m | -388.56m | 1.34bn | 301.00 | -- | 1.15 | -- | 19.47 | -0.5026 | -0.5026 | 0.0889 | 1.47 | 0.0419 | -- | 5.21 | 228,328.30 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | -- | -- |
| TOT Biopharm International Co Ltd | 844.62m | -40.85m | 1.34bn | 463.00 | -- | 1.81 | 354.17 | 1.59 | -0.0563 | -0.0563 | 1.16 | 0.9614 | 0.5808 | 1.87 | 7.75 | -- | -2.81 | -20.01 | -3.72 | -25.21 | 73.53 | 74.74 | -4.84 | -68.53 | 1.48 | -4.60 | 0.3348 | -- | 76.54 | 81.88 | 24.36 | -- | -- | -- |
| Wuhan YZY Biopharma Co Ltd | -100.00bn | -100.00bn | 1.44bn | 123.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -1.50 | -- | -- | -- |
| Mabpharm Ltd | 94.31m | -226.52m | 1.65bn | 347.00 | -- | 7.44 | -- | 17.49 | -0.0549 | -0.0549 | 0.0229 | 0.0538 | 0.0893 | 0.1176 | 6.02 | 271,774.30 | -21.44 | -21.42 | -28.92 | -27.49 | 86.32 | -- | -240.19 | -486.40 | 0.7596 | -19.03 | 0.5591 | -- | 55.87 | -- | 0.694 | -- | -26.85 | -- |
| Hua Medicine | 82.89m | -228.55m | 1.68bn | 177.00 | -- | 14.22 | -- | 20.25 | -0.2338 | -0.2338 | 0.0848 | 0.1118 | 0.0538 | 1.69 | 1.98 | 468,304.10 | -14.84 | -25.61 | -17.56 | -28.81 | 48.78 | -- | -275.73 | -1,654.70 | 6.06 | -- | 0.6238 | -- | 335.31 | -- | -3.80 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -362.26m | 1.69bn | 210.00 | -- | 9.01 | -- | -- | -0.704 | -0.704 | 0.00 | 0.365 | 0.00 | -- | -- | 0.00 | -38.88 | -37.42 | -50.88 | -45.48 | -- | -- | -- | -- | 1.03 | -1.97 | 0.4327 | -- | -- | -- | -5.25 | -- | -- | -- |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.25bn | 352.72m | 1.77bn | 1.14k | 5.03 | 0.5732 | 3.91 | 1.42 | 0.2347 | 0.2347 | 0.8289 | 2.06 | 0.3156 | 2.31 | 6.37 | 1,089,681.00 | 8.85 | 9.89 | 11.36 | 12.49 | 54.60 | 56.69 | 28.03 | 27.89 | 2.26 | 28.89 | 0.0405 | 35.33 | -9.90 | 3.94 | -8.95 | 1.41 | 63.92 | 2.00 |
| Acotec Scientific Holdings Ltd | 512.69m | 15.67m | 1.93bn | 638.00 | 118.36 | 1.38 | 29.42 | 3.77 | 0.0521 | 0.0521 | 1.70 | 4.48 | 0.3136 | 0.7213 | 3.44 | 803,589.30 | 0.9589 | -- | 1.03 | -- | 79.65 | -- | 3.06 | -- | 9.12 | 2.75 | 0.1529 | -- | 19.80 | -- | -79.35 | -- | -- | -- |
| SinoMab Bioscience Ltd | 1.48m | -263.04m | 2.05bn | 233.00 | -- | 6.08 | -- | 1,389.74 | -0.2584 | -0.2584 | 0.0015 | 0.309 | 0.0015 | -- | -- | -- | -26.20 | -24.62 | -32.50 | -27.72 | 30.92 | -- | -17,810.33 | -4,451.74 | -- | -8.15 | 0.604 | -- | -- | -- | 14.45 | -- | -- | -- |
| Cutia Therapeutics | 148.90m | -2.12bn | 2.23bn | 298.00 | -- | 1.52 | -- | 14.98 | -18.28 | -18.28 | 0.7277 | 4.80 | -- | -- | -- | 499,678.30 | -- | -- | -- | -- | 51.60 | -- | -1,426.91 | -- | 5.38 | -- | 0.153 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
| Abbisko Cayman Ltd | 20.62m | -466.96m | 2.32bn | 258.00 | -- | 1.08 | -- | 112.37 | -0.7215 | -0.7215 | 0.0319 | 3.05 | 0.0083 | -- | 1.40 | 79,931.68 | -18.74 | -- | -19.67 | -- | 100.00 | -- | -2,264.34 | -- | -- | -- | 0.0177 | -- | -- | -- | 12.92 | -- | -- | -- |
Data as of Apr 30 2024. Currency figures normalised to Immunotech Biopharm Ltd's reporting currency: Hong Kong Dollar HKD
0.20%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 1.00m | 0.20% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 7.11k | 0.00% |
| BMO Asset Management, Inc.as of 05 Dec 2023 | 1.07k | 0.00% |
| Ping An Fund Management Co., Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
| China Asset Management Co., Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2023 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2023 - 22 Apr 2024Source: FactSet Research Systems Inc.
